{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:50:53Z","timestamp":1790542253291,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","award":["GCC-2017-005"],"award-info":[{"award-number":["GCC-2017-005"]}],"id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopha.2020.110559","type":"journal-article","created":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T13:01:54Z","timestamp":1596286914000},"page":"110559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies"],"prefix":"10.1016","volume":"130","author":[{"given":"Arif","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwarul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mahdi","family":"Nejadi Babadaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir Haj","family":"Bloukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad E.H.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Haghighat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Falahati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110559_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmii.2020.02.001","article-title":"Emerging threats from zoonotic coronaviruses-from SARS and MERS to SARS-CoV2","author":"Lee","year":"2020","journal-title":"Journal of Microbiology, Immunology and Infection"},{"issue":"2","key":"10.1016\/j.biopha.2020.110559_bib0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/v12020194","article-title":"Potential maternal and infant outcomes from (Wuhan) coronavirus SARS-CoV2 infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections","volume":"12","author":"Schwartz","year":"2020","journal-title":"Viruses"},{"issue":"9393","key":"10.1016\/j.biopha.2020.110559_bib0015","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(03)14630-2","article-title":"Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People\u2019s Republic of China, in February, 2003","volume":"362","author":"Zhong","year":"2003","journal-title":"The Lancet"},{"issue":"2004","key":"10.1016\/j.biopha.2020.110559_bib0020","first-page":"1091","article-title":"Epidemiology, transmission dynamics and control of SARS: the 2002\u20132003 epidemic, Philosophical Transactions of the Royal Society of London","volume":"359","author":"Anderson","year":"1447","journal-title":"Series B: Biological Sciences"},{"issue":"2004","key":"10.1016\/j.biopha.2020.110559_bib0025","first-page":"1127","article-title":"The international response to the outbreak of SARS in 2003, Philosophical Transactions of the Royal Society of London","volume":"359","author":"Heymann","year":"1447","journal-title":"Series B: Biological Sciences"},{"issue":"12","key":"10.1016\/j.biopha.2020.110559_bib0030","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/j.socscimed.2006.08.004","article-title":"Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management","volume":"63","author":"Smith","year":"2006","journal-title":"Social science & medicine"},{"issue":"2","key":"10.1016\/j.biopha.2020.110559_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tmaid.2005.04.004","article-title":"The severe acute respiratory syndrome: impact on travel and tourism","volume":"4","author":"Wilder-Smith","year":"2006","journal-title":"Travel medicine and infectious disease"},{"issue":"2","key":"10.1016\/j.biopha.2020.110559_bib0040","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3201\/eid1002.030812","article-title":"Health communication during SARS","volume":"10","author":"Arguin","year":"2004","journal-title":"Emerging infectious diseases"},{"issue":"4","key":"10.1016\/j.biopha.2020.110559_bib0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.prrv.2004.07.005","article-title":"SARS: future research and vaccine","volume":"5","author":"Lau","year":"2004","journal-title":"Paediatric respiratory reviews"},{"key":"10.1016\/j.biopha.2020.110559_bib0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/01.ede.0000181633.80269.4c","article-title":"Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future","author":"Bauch","year":"2005","journal-title":"Epidemiology"},{"issue":"23","key":"10.1016\/j.biopha.2020.110559_bib0055","first-page":"480","article-title":"Update: severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS-CoV)\u2014worldwide, 2012\u20132013","volume":"62","author":"Gastanaduy","year":"2013","journal-title":"MMWR. Morbidity and mortality weekly report"},{"key":"10.1016\/j.biopha.2020.110559_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2016.02.004","article-title":"The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012\u20132015","volume":"45","author":"Alsahafi","year":"2016","journal-title":"International Journal of Infectious Diseases"},{"issue":"10","key":"10.1016\/j.biopha.2020.110559_bib0065","doi-asserted-by":"crossref","first-page":"e792","DOI":"10.1016\/j.ijid.2013.07.002","article-title":"Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)\u2013possible lessons from a systematic review of SARS-CoV therapy","volume":"17","author":"Momattin","year":"2013","journal-title":"International Journal of Infectious Diseases"},{"issue":"5","key":"10.1016\/j.biopha.2020.110559_bib0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tmaid.2014.06.007","article-title":"Travel implications of emerging coronaviruses: SARS and MERS-CoV","volume":"12","author":"Al-Tawfiq","year":"2014","journal-title":"Travel medicine and infectious disease"},{"issue":"9","key":"10.1016\/j.biopha.2020.110559_bib0075","doi-asserted-by":"crossref","first-page":"e668","DOI":"10.1016\/j.ijid.2013.07.001","article-title":"A family cluster of Middle East Respiratory Syndrome Coronavirus infections related to a likely unrecognized asymptomatic or mild case","volume":"17","author":"Omrani","year":"2013","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/j.biopha.2020.110559_bib0080","doi-asserted-by":"crossref","DOI":"10.4178\/epih\/e2015036","article-title":"MERS epidemiological investigation to detect potential mode of transmission in the 178th MERS confirmed case in Pyeongtaek, Korea","volume":"37","author":"Chang","year":"2015","journal-title":"Epidemiology and health"},{"issue":"12","key":"10.1016\/j.biopha.2020.110559_bib0085","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"10.1016\/j.biopha.2020.110559_bib0090","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China","volume":"41","author":"Novel","year":"2020","journal-title":"Zhonghua liu xing bing xue za zhi= Zhonghua liuxingbingxue zazhi"},{"issue":"10223","key":"10.1016\/j.biopha.2020.110559_bib0095","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"10.1016\/j.biopha.2020.110559_bib0100","series-title":"Homology Models of Coronavirus SARS-CoV2 3CLpro Protease","author":"Stoermer","year":"2020"},{"issue":"1","key":"10.1016\/j.biopha.2020.110559_bib0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"Journal of enzyme inhibition and medicinal chemistry"},{"key":"10.1016\/j.biopha.2020.110559_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104212","article-title":"Full-genome evolutionary analysis of the novel corona virus (SARS-CoV2) rejects the hypothesis of emergence as a result of a recent recombination event, Infection","volume":"79","author":"Paraskevis","year":"2020","journal-title":"Genetics and Evolution"},{"issue":"43","key":"10.1016\/j.biopha.2020.110559_bib0115","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.biochem.6b00790","article-title":"Putative receptor binding domain of bat-derived coronavirus HKU9 spike protein: evolution of betacoronavirus receptor binding Motifs","volume":"55","author":"Huang","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.biopha.2020.110559_bib0120","first-page":"1","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","author":"Tai","year":"2020","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.biopha.2020.110559_bib0125","article-title":"Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019\u2010nCoV","author":"Liu","year":"2020","journal-title":"Chembiochem"},{"key":"10.1016\/j.biopha.2020.110559_bib0130","article-title":"Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin","author":"Zhou","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.biopha.2020.110559_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101629","article-title":"Viral loads of SARS, MERS and SARS-CoV-2 in respiratory specimens: What have we learned?","author":"Al-Tawfiq","year":"2020","journal-title":"Travel medicine and infectious disease"},{"key":"10.1016\/j.biopha.2020.110559_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25708","article-title":"Does SARS\u2010CoV\u20102 has a longer incubation period than SARS and MERS?","author":"Jiang","year":"2020","journal-title":"Journal of medical virology"},{"issue":"7798","key":"10.1016\/j.biopha.2020.110559_bib0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.biopha.2020.110559_bib0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"Journal of virology"},{"key":"10.1016\/j.biopha.2020.110559_bib0155","first-page":"1","article-title":"The proximal origin of SARS-CoV-2","author":"Andersen","year":"2020","journal-title":"Nature Medicine"},{"key":"10.1016\/j.biopha.2020.110559_bib0160","article-title":"Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019","author":"Wong","year":"2020","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.biopha.2020.110559_bib0165","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/JVI.02041-07","article-title":"Mechanisms of zoonotic severe acute respiratory syndrome coronavirus host range expansion in human airway epithelium","volume":"82","author":"Sheahan","year":"2008","journal-title":"Journal of virology"},{"issue":"6483","key":"10.1016\/j.biopha.2020.110559_bib0170","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the SARS-CoV2 spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.biopha.2020.110559_bib0175","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2018.12.028","article-title":"Unexpected receptor functional mimicry elucidates activation of coronavirus fusion","volume":"176","author":"Walls","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.biopha.2020.110559_bib0180","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nature medicine"},{"issue":"7","key":"10.1016\/j.biopha.2020.110559_bib0185","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.02377-07","article-title":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge","volume":"82","author":"Rockx","year":"2008","journal-title":"Journal of virology"},{"issue":"33","key":"10.1016\/j.biopha.2020.110559_bib0190","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6965","key":"10.1016\/j.biopha.2020.110559_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.biopha.2020.110559_bib0200","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"10","key":"10.1016\/j.biopha.2020.110559_bib0205","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1128\/JVI.79.10.5900-5906.2005","article-title":"Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants","volume":"79","author":"Sui","year":"2005","journal-title":"Journal of virology"},{"key":"10.1016\/j.biopha.2020.110559_bib0210","first-page":"53","article-title":"Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology, MAbs","author":"Berry","year":"2010","journal-title":"Taylor & Francis"},{"issue":"9427","key":"10.1016\/j.biopha.2020.110559_bib0215","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/S0140-6736(04)16506-9","article-title":"Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets","volume":"363","author":"ter Meulen","year":"2004","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.biopha.2020.110559_bib0220","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1128\/JVI.79.3.1635-1644.2005","article-title":"Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus","volume":"79","author":"van den Brink","year":"2005","journal-title":"Journal of virology"},{"issue":"7","key":"10.1016\/j.biopha.2020.110559_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"Ter Meulen","year":"2006","journal-title":"PLoS medicine"},{"issue":"23","key":"10.1016\/j.biopha.2020.110559_bib0230","doi-asserted-by":"crossref","first-page":"15829","DOI":"10.1074\/jbc.M600697200","article-title":"Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody","volume":"281","author":"Prabakaran","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"29","key":"10.1016\/j.biopha.2020.110559_bib0235","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"8","key":"10.1016\/j.biopha.2020.110559_bib0240","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.biopha.2020.110559_bib0245","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2020.1740560","article-title":"Potential for Developing the SARS-CoV Receptor Binding Domain Recombinant Protein (RBD) as a Heterologous Human Vaccine for SARS-CoV-2","author":"Chen","year":"2020","journal-title":"Hum Vaccin Immunother."},{"issue":"1","key":"10.1016\/j.biopha.2020.110559_bib0250","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.706","article-title":"Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential","volume":"22","author":"Coughlin","year":"2012","journal-title":"Reviews in medical virology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110559_bib0255","first-page":"10","article-title":"Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)","volume":"38","author":"Shanmugaraj","year":"2020","journal-title":"Asian Pacific Journal of Allergy and Immunology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110559_bib0260","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/22221751.2020.1729069","article-title":"Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody","volume":"9","author":"Tian","year":"2020","journal-title":"Emerging microbes & infections"},{"issue":"4","key":"10.1016\/j.biopha.2020.110559_bib0265","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jmb.2009.03.042","article-title":"Structural insights into immune recognition of the severe acute respiratory syndrome coronavirus S protein receptor binding domain","volume":"388","author":"Pak","year":"2009","journal-title":"Journal of molecular biology"},{"issue":"45","key":"10.1016\/j.biopha.2020.110559_bib0270","doi-asserted-by":"crossref","first-page":"34610","DOI":"10.1074\/jbc.M603275200","article-title":"Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R","volume":"281","author":"Hwang","year":"2006","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.biopha.2020.110559_bib0275","first-page":"1","article-title":"Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis","volume":"8","author":"Kirchdoerfer","year":"2018","journal-title":"Scientific reports"},{"key":"10.1016\/j.biopha.2020.110559_bib0280","article-title":"Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS\u2010CoV, MERS\u2010CoV, and 2019\u2010nCoV","author":"Liu","year":"2020","journal-title":"Journal of Medical Virology"},{"issue":"3","key":"10.1016\/j.biopha.2020.110559_bib0285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/jcm9030623","article-title":"Potential rapid diagnostics, vaccine and therapeutics for 2019 novel Coronavirus (SARS-CoV2): a systematic review","volume":"9","author":"Pang","year":"2020","journal-title":"Journal of Clinical Medicine"},{"issue":"8","key":"10.1016\/j.biopha.2020.110559_bib0290","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections\u2014more than just the common cold","volume":"323","author":"Paules","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.biopha.2020.110559_bib0295","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1473-3099(18)30002-1","article-title":"Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study","volume":"18","author":"Beigel","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/j.biopha.2020.110559_bib0300","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac J Allergy Immunol"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:20:08Z","timestamp":1766082008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220307526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S0753332220307526"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110559","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110559","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110559"}}